Amneal Pharmaceuticals, Inc.
AMRXHealthcare|Drug Manufacturers - Specialty & Generic|US
$20.14
+0.69 (+3.55%)
DCF Value
$14.00
Graham Number
$3.96
Cash / Share
$0.47
Clinical Trials (21)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06765668 A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease | Parkinson Disease | P4 | Recruiting | 220 | Open-label | CREXONT ER |
| NCT07138560 BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease | Parkinson Disease | P4 | Recruiting | 22 | Open-label | CREXONT ER |
| NCT07898072 Safety and Efficacy of Weekly Testosterone Cypionate Auto-Injector in Men With Hypogonadism | Male Hypogonadism | P3 | Recruiting | 190 | Double-blind | Testosterone Cypionate 75 mg, Testosterone cypionate 50 mg, Testosterone cypionate 100 mg |
| NCT05401357 Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes. | Glaucoma, Open-Angle, Ocular Hypertension | P3 | Recruiting | 168 | RCT, Single-blind | Test - Bimatoprost 0.01% Ophthalmic Solution, Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution) |
| NCT00404989 Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People. | HIV Infections, Hepatitis B | Recruiting | 24,258 | — | — | |
| NCT01064024 Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo | Pain, Urinary Tract Infections | P3 | Completed | 233 | RCT, Double-blind | Phenazopyridine Hydrochloride, Placebo |
| NCT02110368 Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions | Primary Hypogonadism, Hypogonadotropic Hypogonadism | P3 | Completed | 32 | RCT, Open-label | Testosterone Topical Gel, 1.62% Metered Pump, AndroGel (testosterone gel) 1.62% Metered-Dose Pump |
| NCT03549897 Bronchoprovocation Study to Evaluate the Pharmacodynamics of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base | Asthma | P3 | Unknown | 100 | RCT, Double-blind | Placebo, 90 mcg Reference Product, 180 mcg Reference Product, 90 mcg Test Product |
| NCT02072954 Bioequivalence Fasting Study in Patients | Schizophrenia | P2P3 | Completed | 48 | RCT, Open-label | Asenapine Sublingual Tablets 10 mg, Asenapine Sublingual Tablets 10 mg |
| NCT02125253 Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis | Seasonal Allergic Rhinitis | P3 | Completed | 811 | RCT, Single-blind | Mometasone Furoate Nasal Spray, 50 mcg, Nasonex Nasal Spray, 50 mcg, Placebo Nasal Spray |
| NCT01650051 Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI) | Uncomplicated Urinary Tract Infections | P3 | Completed | 424 | RCT, Double-blind | Placebo of Phenazopyridine Hydrochloride Tables, USP 200 mg, Phenazopyridine Hydrochloride Tables, USP 200 mg |
| NCT02121002 Study Comparing a Generic Diclofenac Sodium Topical Gel, 1% to Voltaren in the Treatment of Subjects With Osteoarthritis of the Knee | Osteoarthritis | P3 | Completed | 1,176 | RCT, Double-blind | Diclofenac Sodium Topical Gel, 1%, Voltaren Topical Gel, 1%, Vehicle Diclofenac Sodium Topical Gel |
| NCT03562923 A Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50 | Asthma | P3 | Unknown | 1,204 | RCT, Double-blind | Test Product, Reference Product, Placebo |
| NCT03562949 A BE Study to Compare Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg and QVAR® 40 mcg, Inhalation Aerosol | Asthma | P3 | Terminated | 761 | RCT, Double-blind | Test Product, Reference Product, Placebo |
| NCT01779947 Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to Placebo | Atrophic Vaginitis Due to Menopause | P3 | Completed | 519 | RCT, Double-blind | Estradiol Vaginal Tablets 10 mcg, placebo |
| NCT02103322 Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions | Chronic Myeloid Leukemia, Gastrointestinal Stromal Tumor | P2P3 | Completed | 48 | RCT, Open-label | Imatinib Mesylate Tablets, 400 mg, Imatinib Mesylate Tablets, 400 mg |
| NCT06267274 A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes | Open-angle Glaucoma, Ocular Hypertension | P1 | Unknown | 240 | RCT, Double-blind | Bimatoprost Ophthalmic Solution, 0.01%, LUMIGAN® (bimatoprost ophthalmic solution) 0.01% |
| NCT02940561 BE Study in Patients - Methotrexate Tablets | Psoriasis, Rheumatoid Arthritis | P1 | Unknown | 48 | RCT, Open-label | Methotrexate - Amneal, Methotrexate - DAVA |
| NCT06467201 SAD Study to Evaluate Safety, Tolerability, and Pharmacokinetic Profile of AMN1126 in Healthy Post-Menopausal Females | Healthy Postmenopausal Women | P1 | Completed | 18 | Open-label | KSHN001126 150mg, KSHN001126 300mg, KSHN001126 600mg |
| NCT01733082 The Mycophenolate Pregnancy Registry | Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases | Completed | 400 | — | — | |
| NCT01067001 Minocycline HCl Extended Release Tablets 135 mg Oral Bioequivalence Study | Fasting | Completed | 18 | — | — |